795 results about "Vaginitis" patented technology

Use of an association of lactobacilli for preparation of a pharmaceutical composition for treatment of vaginosis and vaginitis. Said bacteria association comprises the Lactobacillus brevis and Lactobacillus salivarius subs. salicinius species, possibly in combination with one or more species selected from Lactobacillus salivarius subs. salivarius, Lactobacillus jensenii, Lactobacillus catenaforme, Lactobacillus minutus and Lactobacillus gasseri.A pharmaceutical composition comprising said association of lactobacilli adapted for treatment of vaginosis and vaginitis.A method of treating vaginosis and vaginitis based on administration of said pharmaceutical composition.

There is provided a personal care product having a body side liner, a baffle and an indicator strip with two ends. The indicator has an amine sensitive dye near at least one end. The indicator extends from the target area just below the liner to just above the baffle such that the dye deposit is visible to an unaided eye. The dye changes color in the presence of amines which are characteristic of infection, thus alerting the user to the possibility of infection. Such an indicator placed in a feminine hygiene pad, for example, may be useful in the diagnosis of vaginitis.

The invention discloses a nanocomposite of silver, chitosan and / or a chitosan derivative and a preparation method thereof. The preparation method comprises the steps of evenly mixing the chitosan and / or the chitosan derivative fine powder with silver nitrate fine powder and fully grinding for 1-3 hours with the weight proportion of the chitosan and / or the chitosan derivative to the silver nitrate of 100: 0.0005-0.5; adding a reducing agent with the reduction equivalence ratio of the reducing agent to the silver nitrate of 1: 1-2: 1 and fully grinding for 2-6 hours, thereby obtaining the nanocomposite of the silver, chitosan and / or the chitosan derivative with the silver particle size of 1-100nm. The nanocomposite has the effects of promoting wound healing, stopping bleeding, alleviating pain, anti-inflammation and sterilization, can be used for treating female vaginitis, cervicitis, cervical erosion, bedsores, skin ulcers, burns, scalds, trauma and other skin inflammation, tinea manus and pedis and the like, and can also be used for preparing a variety of trauma dressings, such as thin films, sponges, gynecological suppositories, patches and the like.

The invention discloses a medicinal composition for treating gynecological inflammation, and belongs to the field of Chinese medicament. The medicinal composition consists of collagen and / or Chinese medicaments for releasing toxin and sterilizing such as collagen and lizardtail, glabrous greenbrier rhizome, Vietnamese sophora root and the like which are prepared into a plurality of dosage forms bycombining the prior art, and is mainly used for treating vaginitis, pelvic inflammation, urethritis and cervicitis diseases. The technical scheme overcomes the defects that the prior externally-applied preparations such as lotion, gel, suppository, ointment and the like have extremely slow response, longer disease course, repeated outbreak and the like, and creatively combines and applies the collagen and the Chinese medicament, can accelerate the healing of ulcer and erosion faces caused by the inflammation, and can greatly shorten the required time for tissue repair.

The present invention relates to a pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina which comprises sucrose and / or maltose, to the use of certain sucrose and / or maltose, in preparing the pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, in particular to a method for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, treating the reduction of gram-positive bacilli and the lowness of acidity in vagina as well as the vaginitis and the disturbance of vaginal bacterioflora accompanying the reduction of gram-positive bacilli, especially bacterial vaginal disease.< / PTEXT>

The invention discloses an externally used nanometer silver antibiotic jel line products, which is characterized by the following: constituting with acceptable shaped agent, diluent, slow releasing agent, disperser on nanometer silver and medicinal; setting the grain size of the nanometer silver at 1-25nm; comprising push injecting agent, foam spray, aquagel cleaning solvent, spray and so on of nanometer silver antibiotic jel line products. This invention also relates to the preparing method of nanometer silver colloid and nanometer silver antibiotic jel line products. This product can be used to cure vaginitis, cervicitis, mixing infection type gynaecologic inflammation, prostatitis, prostate proliferation, prostatauxe, male urethritis, balanitis, posthitis and so on.

The invention discloses a solid phase synthesis method and a liquid phase synthesis method of chitosan and / or zinc, silver, bismuth and rare earth metal composite of chitosan derivative. The solid phase synthesis comprises the following steps: (1) grinding chitosan and / or chitosan derivative to fine powder; (2) grinding the oxides of zinc and / or silver and / or bismuth and rare earth metal to fine powder of which content is 0.0005-2wt% of the weight of chitosan and / or chitosan derivative; (3) mixing the fine powders obtained in step (1) and step (2) and fully grinding for 1-6h to obtain the chitosan and / or metal composite of chitosan derivative. The product of the preparation method can be used to cure diseases such as female vaginitis, cervicitis, cervical erosion, bedsore, skin ulcer, fireburn, empyrosis, trauma, other dermatitis disease, tinea of feet and hands and the like and can be used to prepare various surgical dressings such as film, sponge, gynecological suppository, adhesivefilm and the like.

The invention relates to a pomegranate peel polyphenol antibiosis and antiphlogosis effervescent tablet as well as a preparation method and application thereof. The effervescent tablet is mainly prepared by raw material of pomegranate peel polyphenol, and auxiliary materials of sodium hydrogen carbonate, citric acid or tartaric acid, lactose, polyvinylpyrrolidone, magnesium stearate and superfine silica powder, has the functions of clearing heat, eliminating dampness, killing bugs and stopping itching, has strong suppression effect to women vagina pathogenic bacteria, features high safety, good stability, no obvious toxic or side effect, or drug tolerance, and provides convenience in using, carrying and storing for patients, is used for curing such diseases as vaginitis, vulvitis and the like caused by various trichomonad, epiphyte and bacteria, and can be used as preventability medicine for long-term use.

The invention belongs to the field of probiotics and relates to Lactobacillus crispatus SQ1505. The Lactobacillus crispatus SQ1505 has great performances of acid and hydrogen peroxide production and biofilm formation, has an adhesion effect on human vaginal epithelial cells and an antibacterial effect on vaginal pathogenic bacteria, can be used for prevention and treatment of vaginitis and is a new-generation probiotic capable of replacing antibiotics for preventing and treating female reproductive tract infections.

A Chinese medicine in the form of gel, ointment, or suppository for treating cervical erosion, cervicities, and vaginitis is prepared from flavescent sophora root, cnidium fruit and pharmacologically acceptable matrix through extracting, dissolving, mixing with carbomer solution or said matrix, dispersing, and regulating pH=2-12.

The invention relates to Chinese medicine pharmacy techniques and in particular relates to the application of gum extracted from Abelmoschus manihot as a matrix of gynecological gels and a preparation method of Abelmoschus manihot gum. The Abelmoschus manihot gum is extracted from Abelmoschus manihot plants and used as a matrix of Chinese medicinal gels. The invention makes full use of waste plants of Abelmoschus manihot crops, increases the material selection range of Chinese medicinal gel matrixes, reduces cost and waste treatment and pollution, and provides the Chinese medicinal gel matrix which aids in treatment of vaginitis, cervicitis and other gynecological diseases.

A composition for nursing the vagina and treating the gynopathic inflammation such as vaginitis contains the chitosan or its cationic derivative (0.1-99 Wt%). Its preparing process is also disclosed.

The invention relates to compound probiotics and a preparation method thereof. The compound probiotics comprise ten or more probiotics and two or more prebiotics. The invention also provides the preparation method of the compound probiotics. The preparation method comprises the following steps: firstly, mixing the compound probiotics according to the proportion, passing through a sieve with 80 to 120 meshes, then taking siftage and weighing; secondly, mixing the weighed materials; thirdly, tabletting mixed materials. According to the compound probiotics and the preparation method thereof disclosed by the invention, by scientifically mixing the probiotics with the prebiotics, the efficacy of the compound probiotics is effectively improved, living cell concentration is high, and the efficacy realizing time of the probiotics is shortened; compared with other products in the market, the compound probiotics have the advantages that acid and bile salt resisting capabilities are good; if the compound probiotics are administrated for one month, the improvement rate of constipation reaches 100 percent, the improvement rate of chronic colitis reaches 100 percent, the positive-to-negative rate of helicobacter pylori reaches 82 percent, the rehabilitation rate of chemical liver injury reaches 88 percent, the rehabilitation rate of anaphylactic rhinitis is 91 percent, the rehabilitation rate of female vaginitis reaches 93 percent, the improvement rate of phlegm-dampness constitution reaches 100 percent, the improvement rate of damp-heat constitution reaches 100 percent, and the improvement rate of acnes reaches 98 percent.

The invention relates to a Baofukang suppository with an expansion carrier, which is a vaginal suppository prepared by the following components in parts by weight: 60-100 parts of zedoary oil, 60-100 parts of borneol and matrix and 500-2,000 parts of expansion carrier; the surface of the expansion carrier is coated with a drug containing layer formed by at least a part of active ingredients and at least a part of matrix, and the expansion value of the expansion carrier is greater than 1.5. The Baofukang suppository has the benefits that the Baofukang suppository is convenient to use and long in effect time and takes effect fast; the pollution to clothes is avoided; an active drug can be uniformly distributed on a whole vaginal wall and uterine cervix, and permeated into a deep site of mucosa ruffles; surprisingly, the technological effects can still be realized under the conditions that even polyethylene glycol is not used and water is almost not used; the effective rate to mycotic vaginitis is 96.2%; and the effective rate to senile vaginitis is 96.6%.

The invention provides a feed formula for cows in perinatal period. The feed formula comprises following components in parts by mass: 5-8 parts of traditional Chinese medicine composition, 950-1000 parts of basic concentrated feed, 0.03-0.05 parts of vitamin A, 0.15-0.20 parts of vitamin E, 0.01-0.02 parts of vitamin D, 15-17 parts of rumen protected fatty acid calcium, 3-5 parts of calcium hydrophosphate, 1.0-1.5 parts of sodium bicarbonate, 0.01-0.05 parts of ferrous sulfate, 0.08-0.25 parts of zinc sulfate, 0.5-1.0 parts of magnesium oxide, 9-12 parts of glucose, 3-6 parts of brown sugar, 1-2 parts of white sugar, 1-5 parts of edible salt and 0.1-1.0 parts of vegetable oil. Feeding the cows in the perinatal period with the feed formula according to the method, the incidence of gynaecological diseases such as fetal membrane retaining after delivery, endless lochia, postpartum weakness, postpartum pain, childbed fever, endometritis, metrauxe and vaginitis is obviously reduced, both the oestrus rate once again within 30-40 days after the delivery and conception rate once again within 80 days after the delivery are obviously increased, a target of one delivery per year is basically achieved, the use of antibiotics is decreased to enable the cows and calves to be healthy and obtain good beef quality, the cost for producing the calves is also reduced, and a good economic effect is achieved.

The invention discloses novel lactobacillus rhamnosus, namely lactobacillus rhamnosus LR519 which has the preservation number of CGMCC No.15969. The strain has a relatively good effect of inhibiting escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans and other vaginal pathogenic bacteria, can be used for regulating the vaginal microecological balance and maintaining health of female vaginae, can be used for preparing medicines, foods and hygienic products for preventing and treating vaginitis. The invention further discloses compound bacterial powder containing thelactobacillus rhamnosus LR519 and lactobacillus plantarum LP45 and application thereof in medicines, foods and hygienic products for preventing and treating vaginitis.

The present invention provides a strain, which is a Lactobacillus crispatus strain and is characterized in that the preservation number is CGMCC No.6360. The present invention further provides uses of the strain in preparation of drugs for prevention and / or treatment of vaginitis, preparation of vagina care products, and preparation of external genitalia sanitary products. With the technical scheme, antagonism effects of the Lactobacillus crispatus strain on multiple pathogenic bacteria can be achieved. In addition, the strain has high adhesion to vaginal epithelial cells. The strain can well meet practical clinical application requirements.

The invention discloses a drug for treating gynecologic and andrological diseases and a preparation method thereof; calculated according to the portion by weight, the drug is prepared by taking 65 portions to 100 portions of sophora flavescens, 40 portions to 70 portions of radix stemonae, and 40 portions to 70 portions of cortex dictamni as the basic raw materials, and can also be compatible with 40 portions to 70 portions of frutus cnidii and 40 portions to 70 portions of broom cypress fruit. Compared with the prior art, the drug provided by the invention is prepared by the refining of natural Chinese medicinal herb compositions and is combined with modern advanced preparation technology; the prepared product has the functions of clearing away heat and toxic materials, killing insects and removing dirties, relieving swelling and pain, and removing dampness and stopping itching, plays the roles of obviously resisting bacteria, diminishing inflammation, stopping itching, and relieving pain, has good therapeutic effect to fungal, trichomonas, non-specific vaginitis, and can also be used for men scrotum eczema, anal fissure hemorrhoid pain and daily scrotum and anus cleaning; and the drug is safe without toxic and side effects, is not easy for producing drug resistance, is convenient for use and carryover, and has comfortable feeling after the use, thereby leading the patients to be willing to accept the drug.

The invention discloses a liquid-phase synthesis method of silver-chitosan and / or chitosan derivative nanocomposite. The obtained product has the functions of promoting wound surface healing, arresting bleeding, relieving pain, resisting inflammation and sterilizing bacteria, is suitable for female vaginitis, cervicitis, cervical erosion, bedsore, dermal ulcer, burn, scald, trauma, other skin phlogosis, tinea of feet and hands and the like, and can also be used for preparing various trauma dressings such as thin films, sponges, suppositories for gynecology, application films and the like.

The invention discloses a suppository for treating vulvovaginitis, comprising fenticonazole nitrate, glycerogelatin matrix and additives capable of playing a part in slow release. The suppository can have the effects of inhibiting the rapid rise of the blood drug level and prolonging the acting time.

The invention discloses a drug combination for treating dermatosis. The combination is prepared by the following raw materials with certain parts by weight: Galla Chinensis 6-12, Cortex Pseudolaricis 12-24, Radix Sophorae Flavescentis 15-30, Cortex Phellodendri 12-24, Fructus Kochiae 15-30, powdered Sulphur 10-20, Radix Isatidis 8-16, Radix Stemonae 10-20, powdered Calamina 12-24, Hibiscus mutabilis L 8-16, Typhonium gigante um Engl. 10-20, pure Realgar 15-26, Rhizoma Polygonati 10-15, Cinnabaris 8-14, Borneolum, Dexamethasone Tablets 0.25-0.5 or Triamcinolone Acetonide Tablets 0.25-0.5, and Vaseline 1000-2000. The drug combination of the invention belongs to the external-use skin liniment. Years of tests prove that the invention has the advantages of effective and deep disinfection, quick effect and more than 90 percent of effective rate. The invention is applicable for treatment of colpomycosis, mycotic vaginitis and Candida albicans infection; for disinfection and sterilization of skin sensibility and pruritus; and for treatment of foot and hand tinea, tinea manuum, dermatophytosis and balanitis.

The invention relates to active lactic acid bacteria capsules with a treatment and prevention effect on vaginitis. The lactic acid bacteria capsules capable of simultaneously adjusting dysbacteriosis of intestinal tracts and vagina and emphasizing treatment and prevention of the vaginitis are developed for achieving comprehensive effects. According to the technical scheme, excipient and lactic acid bacteria mixed bacteria powder are wrapped in the active lactic acid bacteria capsules with the treatment and prevention effect on vaginitis, and the lactic acid bacteria mixed bacteria powder comprises lactobacillus crispatus powder and other lactic acid bacteria subspecies powder with an effect of adjusting the intestinal flora. The active lactic acid bacteria capsules can be used for treating the vaginitis by adopting oral administration and intra-vaginal use; the oral lactobacillus can effectively improve the immunity of mucosa by stimulating the immune response of the intestinal mucosa, adjust the overall function state of a human body and well treat the vaginitis; and a large quantity of lactobacillus proliferated in the intestinal tract can inhibit growth of intestinal bacteria and reduce the risk of intestinal bacteria infection in vagina.

This invention relates to a new more effective method for problems such as hemorrhoids, vulvo-vaginitis, or similar problems. The reason is that the applicant has observed that the regular dressings and medicated gauzes, the medications will be absorbed by the gauze and may diffuse and contaminate the opposing dress or underwear. Also, when used over places such as abscess, and areas that needs drainage, the pressure over the wound may prevent proper draining. In other cases such as hemorrhoids, the problem is both internal and external, which is also true about vaginitis in which case the involvement is the infection and inflammation of both the inner female organ and the external genitalia. In these circumstances using the medication internally may not be effective for the external problems, but it may also cause contamination of the adjacent areas of the body and underwear as well. For such reasons this new method of medicine application is introduced which will help the treatment and will keep the underwear clean. In this method a special medicated pad is used in which this pad has a non-permeable protective plastic cover outside to prevent the medication from diffusing from the medicated pad and contaminating the skin of the area. The inner medicated part would help the area to heal so that the skin of the area would be treated in the center and would not contaminate the outside as well. Importantly, the surface of this pad may have raised spots to work as a means of massaging the skin or parts of the mucosa. Also, this application introduces new units that are to be used in the anal or vaginal area and that utilize special piece made of a central piece covered with a layer of absorbent or a media that will hold the medication will be mesh or a body of sponge that is inserted into the anal area or vagina to allow its medicated surface to function properly. This piece will be connected to the center of a special medicated pad as mentioned above in order to a treat the outside inflamed area as well. This pad is chosen since it has protective cover outside that prevents a contamination of the skin, as well as an inner part that provides medication to the neighboring skin or mucosa. It is believed that these units can also be used in other cases for special dressings as well. The claims will be provided with regular application.

The invention discloses a herbal composite and a preparation thereof for treating gynecological inflammation. The herbal composite is prepared of cotyledon, selinum, sophora, phellodendron, radix Stemonae, agrimonia, sanqi, borax, borneol; the weight ratios are that 3-15 portions of cotyledon, 3-15 portions of selinum, 3-15 portions of sophora, 2-10 portions of phellodendron, 2-10 portions of radix Stemonae, 2-10 portions of agrimonia, 0.2-2 portions of sanqi, 3.03-0.3 portion of borax, and 0.06-0.6 portion of borneol. The preparation can be suppository, gel, cream, solution agent, film, spray, effervescent tablets agent, and other externally used preparations. The invention adopts common herbal medicines as materials, the usage cost of a sufferer is lower, the content of the effective components are high, the stability is high, and the curative effect is notable. The herbal composite and the preparation of the invention can reduce fever, destroy the toxic properties, dry dampness, kill insect, remove rot, and produce fresh, can inhibit and kill pathogenic micro-organisms and infusorium, can improve the immunity of organism, can cure tickle and relieve pain, can accelerate metabolism, can promote the tissue to rebirth. The prescription is applicable for the sufferers with leukorrhea with reddish discharge, pruritus vulvae, cervical erosion, infusorium vaginitis, mucedine vaginitis, nonspecific vaginitis, etc.

The invention belongs to the technical field of biomedicine, and in particular relates to the application of cathelicidin-BF, an antibacterial peptide of ceratopsia, in the preparation of medicines for treating bacterial vaginosis. The antibacterial peptide cathelicidin-BF of the present invention has the beneficial characteristics of strong bactericidal effect and rapid sterilization on Staphylococcus aureus and Escherichia coli in vitro; the effect of cathelicidin-BF on vaginitis caused by E. The results of coccus-infected vaginitis are basically the same, and it can significantly inhibit Staphylococcus aureus or Escherichia coli in the vagina, and cathelicidin-BF has an obvious effect of reducing inflammation; it can be used in the preparation of drugs for treating bacterial vaginosis.

The invention discloses a vaginitis test kit which comprises a reaction device, a sampling test tube, a straw, joint test diluent, joint test chromogenic reagent, joint test stop solution, a user manual and a joint test colourimetric card, wherein a hydrogen peroxide reaction hole, a leukocyte esterase reaction hole, a sialic acid glucoside enzyme reaction hole, a beta- glucuronic acid enzyme reaction hole, a P glucosidase reation hole and a pH value hole; relevant reaction bases are arranged in the reaction holes; reach reaction base comprises a corresponding reaction substrate curing layer,a chromogenic promotional layer and a chemical inert carrier layer. The invention also provides a preparation method of the test kit and the preparation method of a novel chemical carrier. The test kit can be used for distinguishing bacterial vaginosis and vaginitis, and can further identify aerobic / anaerobic bacteria, facultative anaerobic bacteria and other flora in vaginal secretion. The method is simple and quick to operate, has high accuracy, and is applicable to clinical practice, particularly hospital outpatient practice.

A Chinese medicine in the form of gel for treating vaginitis, cervicities, and cervical erosion is prepared from phellodendron bark, rhubarb, arnebia root and borneol. Its preparing process is also disclosed.

A Chinese medicine in the form of exterior-applied capsule for treating vaginitis, cervical erosion, endometritis, hysteromyoma, and adnexitis is prepared from 7 Chinese-medicinal materials including cnidium fruit, myrrh, frankincense, Dragon's blood, etc.

The invention relates to a gynaecologic lotion relative to female pudendum, which is prepared by extracting glabrous greenbrier rhizome, radix stemonae, cave flower, common cnidium fruit, lightyellow sophora root, phellodendron, European vebena, densefruit pittany root-bark, broom cypress fruit, golden larch bark, shrubalthea bark, Chinese gall, pariphyllin, pericarpium zanthoxyli, indigo naturalis, borneol and white vitriol, and has the effects of reducing fever, detoxifying, eliminating dampness, diminishing inflammation, depriving body fluids, disinfesting insect, stopping leucorrhea, relieving itching, retracting, etc. The lotion can effectively kill pathogenic bacteria, such as trichomonas vaginalis, mucedine, gonococcus, chlamydia, etc., and has the effects of diminishing inflammation, eliminating dampness, stopping leucorrhea and relieving itching. The lotion has good curative effects on various colpitis, multi-colorea leucorrhea, pruritus vulvue, hysteroptosis, prolapse of uterus, vaginal looseness, etc.